Anne Laure Todeschini (Anne-Laure Todeschini)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Pseudomonas Aeruginosa

Transforming Growth Factor

Transcription Factor

Top Venues

British journal of cancer

Cancer research

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Laetitia Herman, Angélique Amo, Berangère Legois, Caterina Di Carlo, Reiner A Veitia, Anne Laure Todeschini
A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. British journal of cancer (2024)
Laetitia Herman, Angélique Amo, Berangère Legois, Caterina Di Carlo, Reiner A Veitia, Anne Laure Todeschini
A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. British journal of cancer 130 (9) (2024)
Laetitia Herman, Angélique Amo, Berangère Legois, Caterina Di Carlo, Reiner A Veitia, Anne Laure Todeschini
A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. British journal of cancer 130 (9) (2024)
Laetitia Herman, Angélique Amo, Berangère Legois, Caterina Di Carlo, Reiner A Veitia, Anne Laure Todeschini
A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. British journal of cancer 130 (9) (2024)
Laetitia Herman, Angélique Amo, Berangère Legois, Caterina Di Carlo, Reiner A Veitia, Anne Laure Todeschini
A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. British journal of cancer (2024)
Laetitia Herman, Angélique Amo, Berangère Legois, Caterina Di Carlo, Reiner A Veitia, Anne Laure Todeschini
A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. British journal of cancer 130 (9) (2024)
Elena Llano, Anne Laure Todeschini, Natalia Felipe-Medina, María Daniela Corte-Torres, Yazmine B Condezo, Manuel A Sanchez-Martin, Sara López-Tamargo, María Aurora Astudillo, Xose S Puente, Alberto M Pendas, Reiner A Veitia
The oncogenic FOXL2 C134W mutation is a key driver of granulosa cell tumors. Cancer research (2022)
Laetitia Herman, Bérangère Legois, Anne Laure Todeschini, Reiner A Veitia
Genomic exploration of the targets of FOXL2 and ESR2 unveils their implication in cell migration, invasion, and adhesion. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 35 (4) (2021)